EAM Investors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-22,442
| Closed | -$3.84M | – | 285 |
|
|
2018
Q3 | $3.84M | Sell |
22,442
-1,709
| -7% | -$293K | 0.57% | 38 |
|
|
2018
Q2 | $3.12M | Sell |
24,151
-9,539
| -28% | -$1.23M | 0.49% | 82 |
|
|
2018
Q1 | $3.47M | Buy |
+33,690
| New | +$3.47M | 0.58% | 43 |
|
|
2015
Q4 | – | Sell |
-35,426
| Closed | -$1.89M | – | 339 |
|
|
2015
Q3 | $1.89M | Sell |
35,426
-8,233
| -19% | -$440K | 0.3% | 154 |
|
|
2015
Q2 | $2.75M | Sell |
43,659
-29,064
| -40% | -$1.83M | 0.32% | 148 |
|
|
2015
Q1 | $3.5M | Buy |
+72,723
| New | +$3.5M | 0.4% | 79 |
|
|
2014
Q3 | – | Sell |
-27,674
| Closed | -$1.08M | – | 338 |
|
|
2014
Q2 | $1.08M | Sell |
27,674
-13,449
| -33% | -$522K | 0.2% | 282 |
|
|
2014
Q1 | $1.73M | Sell |
41,123
-5,944
| -13% | -$249K | 0.31% | 118 |
|
|
2013
Q4 | $1.54M | Sell |
47,067
-56
| -0.1% | -$1.84K | 0.28% | 138 |
|
|
2013
Q3 | $1.27M | Sell |
47,123
-79,980
| -63% | -$2.16M | 0.25% | 156 |
|
|
2013
Q2 | $2.97M | Buy |
+127,103
| New | +$2.97M | 0.64% | 21 |
|